Responsive Ad Slot

Latest

Sponsored

Features

Buhay Pinay

People

Sports

Philippine News

Join us at Facebook!

Health experts say kids as young as 3 may take Sinovac

15 November 2021

By The SUN 

Sinovac is now cleared for use for people aged 3 years old and up

A panel of experts advising the government on its vaccination program for Covid-19 has recommended the use of Sinovac vaccine for kids as young as three years old.

A government statement released late on Monday said the recommendation was made after the experts met to discuss the safety and efficacy of administering Sinovac and BioNTech vaccines to younger children.

Call now!

“The relevant information indicated that the Sinovac vaccine had good safety when administered on children aged three to 17 of different ethnicities,” said the statement.

PRESS FOR DETAILS!
 

Before giving the green light for the use of Sinovac on younger children, the experts said they reviewed information supplied by the mainland-based drug company, including phase 1 and 2 clinical trial data published in medical journals; real-world safety data collected in the mainland; and preliminary data from phase 3 clinical trials in countries such as South Africa and Chile.

CLICK FOR DETAILS
 

As for using BioNTech on children aged five to 11, the experts said the government should ask for more information from its supplier, Fosun Pharma. Currently, the vaccine is recommended for use by youngsters aged 12 to 17 years old.

How? Press this ad.

 

Currently, Hong Kong residents aged 12 and above are eligible to receive free vaccination. The minimum age for receiving BioNTech is 12, and 18 for Sinovac. 
The government said it welcomed the recommendation by the advisory panel on lowering the age requirement for Sinovac vaccine and will follow up with Fosun Pharma on whether BioNTech can be used on children aged 5 to 11.
BASAHIN ANG KWENTONG DREAM LOVE

 

As part of the authorizations granted to the two vaccines by the Secretary for Food and Health early this year, their suppliers are required to submit the latest clinical data on the vaccines, safety update reports and other relevant data for continuous review and monitoring.


PINDUTIN PARA SA DETALYE
Don't Miss